Iwasawa Takumi 岩澤卓弥

Researcher Number	70906297
Other IDs
Affiliation (Current)	2026: 東洋大学, ライフイノベーション研究所, 研究助手
Affiliation (based on the past Project Information) *help	2023 – 2025: 東洋大学, ライフイノベーション研究所, 研究助手 2022: 東洋大学, 生体医工学研究センター, 研究助手
Review Section/Research Field	Principal Investigator Basic Section 53020:Cardiology-related Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 49020:Human pathology-related
Keywords	Principal Investigator 腸内細菌 / 分子抗原群 / 免疫制御 / 炎症 / アテローム性動脈硬化症 / ミエロイド系免疫抑制細胞 Except Principal Investigator 放射性化合物 / EphA2 / ラジオセラノスティクス / エストロゲン … More / 骨髄由来抑制細胞 / マクロファージ / 腫瘍浸潤リンパ球 / 癌微小環境 / エストロゲン受容体 / 卵巣癌 / アルファ線核種 / がん標的抗体 / がん / 抗体治療 / EphA2抗体 / 111-In / SPECTトレーサー / 177－Lu / 繊維肉腫 / 111-インジウム / 177-ルテシウム / EphA2受容体 / 177-Lu / セラノスティクス / がん特異抗体 / 核医学治療 / 画像診断 / ジルコニウム89 / ルテチウム177 / 癌標的化抗体 Less

The development of EphA2-targeted alpha-particle therapy aimed at practical application for the treatment of rare cancers
- Principal Investigator
  
  加藤和則
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Toyo University
Research for cancer radio-theranostics drugs using anti-EphA2 antibodies
- Principal Investigator
  
  KATO KAZUNORI
- Project Period (FY)
  2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Toyo University
エストロゲンシグナルを介した癌微小環境制御による卵巣癌治療戦略
- Principal Investigator
  
  佐伯春美
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Juntendo University
Functional molecules that regulate atherosclerosis by targeting novel myeloid immunosuppressor cellsPrincipal Investigator
- Principal Investigator
  
  岩澤卓弥
- Project Period (FY)
  2024 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Toyo University

All 2025 2024 2023

All Journal Article Presentation

[Journal Article] Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)2025
- Author(s)
  Watabe Tadashi、Iwasawa Takumi、Kimura Hiroyuki、Shirakami Yoshifumi、Naka Sadahiro、Kaneda Kazuko、Kobayashi Takanori、Omokawa Marina、Yagi Yusuke、Tomiyama Noriyuki、Kato Kazunori
- Journal Title
  
  European Journal of Nuclear Medicine and Molecular Imaging
  
  Volume: - Issue: 8 Pages: 2887-2897
- DOI
  10.1007/s00259-025-07139-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24189, KAKENHI-PROJECT-22K15852, KAKENHI-PROJECT-24K02395, KAKENHI-PROJECT-24K19013
[Journal Article] Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer2024
- Author(s)
  Sakuraba Shunsuke、Koizumi Akihiro、Iwasawa Takumi、Ito Tomoaki、Kato Kazunori
- Journal Title
  
  Biomolecules
  
  Volume: 14 Issue: 12 Pages: 1504-1504
- DOI
  10.3390/biom14121504
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24189, KAKENHI-PROJECT-20K16366, KAKENHI-PROJECT-24K19013
[Journal Article] Semiconductor Transistor-Based Detection of Epithelial-Mesenchymal Transition via Weak Acid-Induced Proton Perturbation2024
- Author(s)
  Sakata Momoko、Imaizumi Yuki、Iwasawa Takumi、Kato Kazunori、Goda Tatsuro
- Journal Title
  
  ACS Biomaterials Science & Engineering
  
  Volume: 11 Issue: 1 Pages: 586-594
- DOI
  10.1021/acsbiomaterials.4c01707
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24K19013
[Journal Article] Novel [ 111 In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA22023
- Author(s)
  T. Furukawa, H. Kimura, M. Sasaki, T. Yamada, T. Iwasawa, Y. Yagi, K. Kato, H. Yasui
- Journal Title
  
  ACS Omega
  
  Volume: 8 Issue: 7 Pages: 7030-7035
- DOI
  10.1021/acsomega.2c07849
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24189, KAKENHI-PROJECT-22K15852
[Presentation] Application of radiopharmaceuticals using EphA2-targeted antibodies for diagnosis of pancreatic cancer2024
- Author(s)
  R Kunito , H Kimura , M Omokawa , S Kise , T Iwasawa , K Kato , A Mizutani , K Kawai
- Organizer
  CJKSRS2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] 食事が創る免疫：がん治療における栄養の力2024
- Author(s)
  岩澤卓弥
- Organizer
  第22回日本機能性食品医用学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] Soluble B7H3 has a potential of novel serum biomaker for colorectal cancer2024
- Author(s)
  A Koizumi, T Ito, K Kato, T Iwasawa, T Kushida, K Sato, C Okamoto
- Organizer
  AACR 2024 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] Effects of Phytochemicals on mouse bone marrow-derived dendritic cells2024
- Author(s)
  Kaho Oki , Takumi Iwasawa , Kazunori Kato
- Organizer
  The 53rd Annual Meeting of the Japanese Society for Immunology
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] 免疫チェックポイント阻害療法に対する乳酸菌代謝物の増強効果2024
- Author(s)
  岩澤卓弥 , 山内卓 , 伊藤智彰 , 福永哲 , 折田創 , 野村幸世 , 加藤和則
- Organizer
  第22回日本機能性食品医用学会総会
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] Synergistic Effects of Immune Checkpoint Inhibition Therapy with Lactobacillus Metabolites2024
- Author(s)
  Takumi Iwasawa , Suguru Yamauchi , Tomoaki Ito , Kazunori Kato
- Organizer
  The 53rd Annual Meeting of the Japanese Society for Immunology
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] NK細胞活性を促進するファイトケミカルの探索研究2024
- Author(s)
  LIN YIKUN , 岩澤卓弥 , 加藤和則
- Organizer
  第22回日本機能性食品医用学会総会
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] A novel subset of Treg-like MDSCs expressing LAG-3 found in advanced gastric cancer2024
- Author(s)
  T. Iwasawa , S. Yamauchi , T. Fukunaga , H. Orita , T. Ito , K. Kato
- Organizer
  AACR 2024 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] Whole-genome methylation analysis using liquid biopsy for pancreatic cancer diagnosis2024
- Author(s)
  T. Ito , T. Iwasawa , S. Takeda , C. Okamoto , T. Motohashi , S. Ueda , H. Kato , R. Yamamoto , A. Koizumi , Y. Murai , K. Nihei , M. Itakura , R. Akima , M. Sakurada , K. Tanaka , T. Kushida , K. Sato
- Organizer
  AACR 2024 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] Nobiletin elevates anti-tumor effects of DM-1conjugated ADC2024
- Author(s)
  増岡知也、岩澤卓弥、山田拓武、加藤和則
- Organizer
  第83回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] Soluble B7H3 has a potential of novel serum biomaker for colorectal cancer2024
- Author(s)
  A. Koizumi , T. Ito , K. Kato , T. Iwasawa , T. Kushida , K. Sato , C. Okamoto
- Organizer
  AACR 2024 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] γδT細胞の機能調節に働く植物由来機能性成分の探索研究2024
- Author(s)
  石橋歩士 , 岩澤卓弥 , 加藤和則
- Organizer
  第47回日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] Attempts to Enhance the Action of Immune Checkpoint Inhibitory Therapy with Lactobacillus Metabolites2024
- Author(s)
  岩澤卓弥 , 山内卓 , 伊藤智彰 , 加藤和則
- Organizer
  第83回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] 線維化疾患を標的とする植物由来機能性成分の機能解析2024
- Author(s)
  小山輝 , 岩澤卓弥 , 加藤和則
- Organizer
  第47回日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-24K19013
[Presentation] 111-In標識-抗EphA2受容体抗体によるSPECTプローブの合成と評価2023
- Author(s)
  佐々木美音、木村寛之、古川武典、山田拓武、岩澤卓弥、加藤和則、安井裕之
- Organizer
  日本薬学会第143年会
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] ノビレチンを始めとしたポリメトキシフラボノイドのがん補助療法への応用を目指した基盤研究2023
- Author(s)
  岩澤卓弥、加藤和則
- Organizer
  日本機能性食品医用学会
- Invited
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] ポリメトキシフラボノイドは抗体薬物複合体の抗腫瘍効果を増強する2023
- Author(s)
  増岡知也、岩澤卓弥、米澤貴之、渡辺章夫、禹済泰、加藤和則
- Organizer
  日本薬学会第143年会
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] Novel subset of granulocytic MDSCs as immunosuppressive regulators and therapeutic targets in gastric cancer.2023
- Author(s)
  T. Iwasawa, S. Yamauchi, T. Fukunaga, H. Orita and K. Kato
- Organizer
  116th Annual Meeting of American Association of Cancer Research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K24189
[Presentation] Enhancement of anti-tumor effect of antibody-drug conjugate in combination with nobiletin and othe PMFs.2023
- Author(s)
  T. Masuoka, T. Iwasawa, T. Yonezawa, A. Watanabe, J. Woo and K. Kato
- Organizer
  第82回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K24189

1. KATO KAZUNORI (60233780)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
2. 木村寛之 (50437240)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
3. 渡部直史 (90648932)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
4. 白神宜史 (00560400)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 佐伯春美 (20535603)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 安川武宏 (90646720)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 藤野一成 (40543666)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Iwasawa Takumi 岩澤 卓弥

Research Projects

Research Products

Co-Researchers

The development of EphA2-targeted alpha-particle therapy aimed at practical application for the treatment of rare cancers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research for cancer radio-theranostics drugs using anti-EphA2 antibodies

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

エストロゲンシグナルを介した癌微小環境制御による卵巣癌治療戦略

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functional molecules that regulate atherosclerosis by targeting novel myeloid immunosuppressor cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Semiconductor Transistor-Based Detection of Epithelial-Mesenchymal Transition via Weak Acid-Induced Proton Perturbation2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel [ 111 In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA22023

Author(s)

Journal Title

DOI

Data Source

[Presentation] Application of radiopharmaceuticals using EphA2-targeted antibodies for diagnosis of pancreatic cancer2024

Author(s)

Organizer

Data Source

[Presentation] 食事が創る免疫：がん治療における栄養の力2024

Author(s)

Organizer

Data Source

[Presentation] Soluble B7H3 has a potential of novel serum biomaker for colorectal cancer2024

Author(s)

Organizer

Data Source

[Presentation] Effects of Phytochemicals on mouse bone marrow-derived dendritic cells2024

Author(s)

Organizer

Data Source

[Presentation] 免疫チェックポイント阻害療法に対する乳酸菌代謝物の増強効果2024

Author(s)

Organizer

Data Source

[Presentation] Synergistic Effects of Immune Checkpoint Inhibition Therapy with Lactobacillus Metabolites2024

Author(s)

Organizer

Data Source

[Presentation] NK細胞活性を促進するファイトケミカルの探索研究2024

Author(s)

Organizer

Data Source

[Presentation] A novel subset of Treg-like MDSCs expressing LAG-3 found in advanced gastric cancer2024

Author(s)

Organizer

Data Source

Iwasawa Takumi 岩澤卓弥